Rahul Barot

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Design, synthesis, biological evaluation and molecular dynamics of some novel 3-phenylpyrazolo[1,5- a ]pyrimidine-2,7(1 H ,4 H )-dione based compounds as anti-tubercular agents
  Monica Chauhan, Chintu Prajapati, S. A. Mirza +10 more
  Journal of Biomolecular Structure and Dynamics 2024 DOI: 10.1080/07391102.2023.2249109
  +Save
• Exploring Decaprenylphosphoryl-β-D-ribose 2’-Epimerase 1 (DprE1): A Target for Anti- Tubercular Drugs
  TUBERCULOSIS: Integrated Studies for a Complex Disease 2023
  +Save
• Role of Computational Modeling in Drug Discovery for Alzheimer’s Disease
  Current Trends in Computational Modeling for Drug Discovery 2023 DOI: 10.1007/978-3-031-33871-7
  +Save
• Biological Activity Spectrum of Oxadiazoles as a Privileged Scaffold in Medicinal Chemistry
  Advances in Medicine and Biology 2021
  +Save
• Recent developments and strategies for the discovery of TACE inhibitors
  Prashant Revan Murumkar, Rahul B. Ghuge, Monica Chauhan +5 more
  Expert Opinion on Drug Discovery 2020 DOI: 10.1080/17460441.2020.1744559
  +Save
• Development of Steroidal Aromatase Inhibitors as Potential Anti-breast Cancer Agents
  Rahul B. Ghuge, Prashant Revan Murumkar, Kailash M. Choudhary +4 more
  Current Enzyme Inhibition 2020 DOI: 10.2174/1573408016666200212094804
  +Save
• Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents
  Ashish D. Patel, Rahul R. Barot, Inaxi Parmar +4 more
  Current Computer-Aided Drug Design 2018 DOI: 10.2174/1573409914666180426125721
  +Save